FDA panel rejects combination pain pill

April 22, 2014

Federal health advisers have unanimously rejected an experimental pain pill that combines two common opioids, oxycodone and morphine.

The , Moxduo, was developed by QRxPharma with the aim of decreasing dangerous side effects of , including , nausea and vomiting. The company theorized that combining lower doses of the two drugs would be safer and more effective than taking higher doses of the drugs separately.

But FDA advisers say that the company's studies of Moxduo did not show any advantages over regular oxycodone and morphine.

The FDA's 14 pain specialists all voted against approving the drug. The FDA is not required to follow the panel's recommendation.

A half-dozen public speakers urged the FDA to reject the drug at the Tuesday meeting, citing its potential for abuse.

Explore further: US panel opposes pure hydrocodone painkiller

Related Stories

US panel opposes pure hydrocodone painkiller

December 9, 2012

(AP)—U.S. government health experts overwhelmingly voted against a stronger version of hydrocodone on Friday, questioning the need for a new form of one of most widely abused prescription painkillers.

FDA advisers unanimously back J&J hepatitis C drug

October 24, 2013

An experimental hepatitis C drug from Johnson & Johnson has won unanimous support from government experts who say the medication should be approved to treat patients infected with the liver-destroying virus.

FDA panel again rejects wider use of J&J's Xarelto

January 16, 2014

A panel of Food and Drug Administration experts again opposed expanding use of Johnson & Johnson's blood thinner Xarelto to reduce dangerous blood clots in a new group of patients, those with acute coronary artery disease.

Recommended for you

Treatment options for opioid addiction are expanding

August 10, 2016

In the past two decades, the devastation associated with opioid addiction has escaped the relative confines of the inner city and extended to suburban and rural America. Due in large part to the proliferation of prescription ...

Can exercise be replaced with a pill?

October 2, 2015

Everyone knows that exercise improves health, and ongoing research continues to uncover increasingly detailed information on its benefits for metabolism, circulation, and improved functioning of organs such as the heart, ...

FDA bolsters warnings about class of antibiotics

July 26, 2016

(HealthDay)—The U.S. Food and Drug Administration announced Tuesday that it's strengthening label warnings on a class of antibiotics called fluoroquinolones because the drugs can lead to disabling side effects, including ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.